Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms and management of cardiomyopathies Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by